Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FL68T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,297
Award facts
- Contract value 100% obligated
- $29,297.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) valued at $29,297.11 under a firm fixed-price contract. The award, made on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
This contract delivery exemplifies AmerisourceBergen Drug Corp's extensive portfolio in federal medical supply, which encompasses vaccines, pharmaceuticals, and specialized medical commodities across multiple therapeutic domains. The firm fixed-price delivery order model reflects the Defense Logistics Agency's approach to fulfilling specific medical supply requirements through competitively awarded transactions. As a prime vendor under the DLA's pharmaceutical procurement framework, AmerisourceBergen Drug Corp supplies critical healthcare commodities to support Defense Health Agency operations and other government healthcare systems worldwide, demonstrating the company's established capability to meet federal medical supply specifications and delivery timelines.
Quick answers
Who was awarded contract SPE2DB25FL68T?
SPE2DB25FL68T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FL68T worth?
The government has obligated $29,297 on SPE2DB25FL68T.
Is contract SPE2DB25FL68T an order under another contract?
Yes. SPE2DB25FL68T is a delivery order under SPE2DB20D2002, an indefinite delivery contract.
Was contract SPE2DB25FL68T competed?
The extent of competition for SPE2DB25FL68T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award